Cascadian Therapeutics (USA) (CASC) At $3.60 Forms Bottom, Profile of 1 Analysts Covering TransAlta (TSE:TA)

June 28, 2017 - By Vivian Park

Among 4 analysts covering TransAlta Corporation (TSE:TA), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. TransAlta Corporation had 34 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of TransAlta Corporation (TSE:TA) earned “Underperform” rating by Scotia Capital on Thursday, August 11. The stock of TransAlta Corporation (TSE:TA) has “Hold” rating given on Friday, April 21 by TD Securities. As per Wednesday, August 26, the company rating was upgraded by TD Securities. The rating was upgraded by National Bank Canada on Monday, September 28 to “Outperform”. The firm has “Market Perform” rating given on Tuesday, May 23 by BMO Capital Markets. The firm has “Underperform” rating given on Tuesday, August 25 by IBC. Scotia Capital maintained it with “Sector Perform” rating and $6.50 target in Friday, November 25 report. Scotia Capital maintained TransAlta Corporation (TSE:TA) rating on Thursday, July 23. Scotia Capital has “Sector Outperform” rating and $14 target. The stock has “Hold” rating by TD Securities on Thursday, December 1. BMO Capital Markets maintained TransAlta Corporation (TSE:TA) rating on Wednesday, January 4. BMO Capital Markets has “” rating and $8 target. See TransAlta Corporation (TSE:TA) latest ratings:

23/05/2017 Broker: BMO Capital Markets Rating: Market Perform New Target: $8.00 Maintain
21/04/2017 Broker: TD Securities Rating: Hold New Target: $8.00 Maintain
04/01/2017 Broker: BMO Capital Markets Rating: New Target: $8.00 Maintain
04/01/2017 Broker: Credit Suisse Rating: New Target: $7.00 Maintain
04/01/2017 Broker: National Bank Canada Rating: Outperform New Target: $9.00 Maintain

Cascadian Therapeutics Inc (USA) (CASC) formed multiple bottom with $3.31 target or 8.00% below today’s $3.60 share price. Cascadian Therapeutics Inc (USA) (CASC) has $186.16M valuation. The stock decreased 9.32% or $0.37 during the last trading session, reaching $3.6. About shares traded. Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) has declined 30.85% since June 28, 2016 and is downtrending. It has underperformed by 47.55% the S&P500.

Since May 30, 2017, it had 1 buy, and 0 selling transactions for $40,500 activity. LOMBARDI MICHAEL J bought $40,500 worth of stock.

The stock decreased 0.25% or $0.02 on June 27, reaching $8.01. About 501,181 shares traded. TransAlta Corporation (TSE:TA) has 0.00% since June 28, 2016 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment increased to 1.24 in 2016 Q4. Its up 0.17, from 1.07 in 2016Q3. It is positive, as 13 investors sold TransAlta Corporation shares while 21 reduced holdings. 13 funds opened positions while 29 raised stakes. 15.10 million shares or 5.78% less from 16.02 million shares in 2016Q3 were reported. Northwestern Mutual Wealth Mngmt Com has invested 0% in TransAlta Corporation (TSE:TA). Citigroup holds 0% or 1,638 shares. Bridgeway Capital Management invested in 0.04% or 409,250 shares. 54,500 are owned by Deprince Race & Zollo. Rech Glob Investors accumulated 2.02M shares. 64,280 were accumulated by Art Advsr Ltd Limited Liability Company. Bb&T Securities Llc holds 0% or 34,000 shares. Blackrock Fund Advsr has 0% invested in TransAlta Corporation (TSE:TA) for 5,144 shares. Geode Cap Mgmt Limited Liability Co owns 21,631 shares. Alexandria Capital Limited Liability Co has invested 0.01% in TransAlta Corporation (TSE:TA). Jpmorgan Chase holds 0% or 9,557 shares in its portfolio. Blackrock Institutional Company Na invested 0% in TransAlta Corporation (TSE:TA). 17 were reported by Walleye Trading Ltd Limited Liability Company. Levin Cap Strategies Limited Partnership holds 20,000 shares or 0% of its portfolio. State Street Corporation reported 0% in TransAlta Corporation (TSE:TA).

TransAlta Corporation is a non-regulated electricity generation and energy marketing firm with an aggregate net ownership interest of approximately 8,720 megawatts of generating capacity. The company has market cap of $2.31 billion. The Firm is engaged in the production and sale of electric energy. It has a 41.94 P/E ratio. It focuses on generating and marketing electricity in Canada, the United States and Western Australia through its diversified portfolio of facilities fuelled by coal, natural gas, diesel, hydro, wind and solar.